Welcome to Printing Life

CellDrive 3D, S.L. was established on December 2020 as a start-up recognized as a Knowledge-Based Company. The Science Equity fund Beable Capital and the Valladolid University (Spain), through his research group Bioforge, which constitutes a multidisciplinary group focused on advanced systems for medicine and bioengineering applications, form part of the promoter team. CellDrive 3D main research interest is the development of personalized, intelligent, biofunctional protein polymers for advanced biomedical devices.
Our majority partner, Beable Capital SGEIC SA, Venture of reference in Science Equity (Technology Transfer funds focused on Deep Science), through its fund BeAble Innvierte Kets Fund, FCR, invests in Seed and Early Stage in Disruptive Technologies with sustainable competitive advantages based on the company’s Intellectual Property and know-how and high added value that fulfill non-covered needs on high growth markets.


CellDrive 3D features a one-of-a-kind bioink platform obtained through genetic engineering techniques to create living tissue on demand. Its formulation, free of animal components, mimics the extracellular matrix, maximizing the cell viability of embedded cells and 3D resolution. Patented Thecnology.
Live/dead staining of 3D-printed scaffolds loaded with HaCaT (8 × 106 cells/mL) and HUVEC (2 × 107 cells/mL) cells into the CD3D ELR BioInk RGD, and incubated during a culture period of 1, 3, 7, and 14 days.
Living cells were stained with calcein AM (green fluorescence), and death cells by ethidium homodimer (red fluorescence).
Staining of filamentous actin (F-actin) (red) and cell nuclei (blue) in 3D-printed scaffolds stained with Rhodamine phalloidin and DAPI, respectively, and loaded with HFF-1-HaCaT co-cultures (6 × 106-6 × 106 cells/mL) after 7 days of incubation. Volume reconstruction of the 0.5 μm-z-steps.


CD3D ELR BioInk RGD has been designed using recombinant DNA technology for easy 3D printing. It constitutes a novel biological material based on human elastin sequence that is biomimetic, biocompatible, and biodegradable.
Furthermore, our bioink exhibits the necessary mechanical properties to fulfill an excellent printability and achieve a long-term stability of the final construction without the need for crosslinkers nor photoinitiators. It is supplied sterile, ready to use, and represents an excellent choice for various 3D bioprinting applications in tissue engineering and regenerative medicine.
In addition, it can be used to 3D-print scaffolds embedded with cells for the development of in vitro tissue models, and to encapsulate drugloaded nanoparticles for drug screening and drug delivery.
bioink concentration
scaffold consistency
easy handing
Our CD3D ELR BioInk RGD is available in three different formats according to the concentration of the product, that is, low, medium, and high. Choosing the concentration of the bioink, allows you to control the consistency of the 3D-printed structures based on your specific requirements and applications.
tabla product

Biomedical applications:

drug development
Drug development models
in vitro tissue model
In vitro tissue models
terapeutic tissue
Therapeutic tissues
drug delivery
Drug delivery

Contact Us

Send us an email and tell us what else you want to know about our BioInk:
Or give us a call. We will be happy to assist you and discuss any question you may have about us:
+34 983 003 021
Avenida Francisco Vallés, 8
47151 – Boecillo (Valladolid) Spain
T. +34 983 003 021